These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3095124)

  • 1. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta.
    Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N
    Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y; Sakane T; Tsunematsu T
    J Immunol; 1989 Dec; 143(12):3988-93. PubMed ID: 2592765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.
    Kitani A; Hara M; Hirose T; Norioka K; Harigai M; Hirose W; Suzuki K; Kawakami M; Kawagoe M; Nakamura H
    Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
    Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D
    Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T; Aubry JP; Vanbervliet B; Banchereau J
    J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of recombinant IL 2 and interferon-gamma on the proliferation of human monoclonal lymphocytes.
    Karray S; Vazquez A; Merle-Beral H; Olive D; Debre P; Galanaud P
    J Immunol; 1987 Jun; 138(11):3824-8. PubMed ID: 3108376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
    J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T
    Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
    Funauchi M; Sugishima H; Minoda M; Horiuchi A
    J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.